Free Trial

Organigram (TSE:OGI) Shares Up 2% - Here's Why

Organigram logo with Medical background

Organigram Holdings Inc. (TSE:OGI - Get Free Report) rose 2% on Wednesday . The stock traded as high as C$2.05 and last traded at C$2.00. Approximately 201,555 shares traded hands during trading, a decline of 3% from the average daily volume of 207,436 shares. The stock had previously closed at C$1.96.

Organigram Stock Down 0.5%

The company has a market cap of C$245.85 million, a price-to-earnings ratio of -4.21, a PEG ratio of 0.42 and a beta of 1.13. The business has a 50-day simple moving average of C$1.65 and a two-hundred day simple moving average of C$1.86. The company has a quick ratio of 2.62, a current ratio of 3.36 and a debt-to-equity ratio of 3.07.

Organigram Company Profile

(Get Free Report)

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

Further Reading

Should You Invest $1,000 in Organigram Right Now?

Before you consider Organigram, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.

While Organigram currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines